OM1 Reviews

AdvancedMD is the all-in-one cloud-based medical office software trusted by thousands of independent practices to run smarter, faster, and more profitably. It unifies practice management, EHR, and patient engagement into a single seamless platform — eliminating the inefficiencies of disconnected systems. The AI Clinical Assistant is at the core of the modern AdvancedMD experience. It powers ambient listening and auto-transcription, capturing patient conversations and turning them into structured chart documentation in moments — reducing note-writing from 15 minutes to seconds. AI-generated chart action items, pre-visit summaries, and insurance card capture further eliminate manual data entry, so your staff spends less time on paperwork and more time with patients. AI Narrative Insights continuously analyzes practice performance data, surfacing trends and opportunities you can act on directly from your dashboard. On the financial side, AdvancedMD strengthens your bottom line with robust revenue cycle management, a multi-clearinghouse model including a Waystar partnership for cleaner claims, and computer-assisted coding to maximize reimbursement. The result: faster payments, fewer denials, and healthier cash flow. Built on secure AWS infrastructure with Password Breach Detection, AdvancedMD keeps your practice protected and compliant — accessible from any device, anywhere, anytime. Whether you're a solo provider or a growing multi-specialty group, AdvancedMD scales with you — delivering an intelligent, unified experience that lets you focus on what matters most: your patients. The future of independent practice isn't just surviving — it's thriving. AdvancedMD gives you the technology to do both, without the complexity.

Concentrate your efforts on delivering outstanding, data-informed care using Valant, the comprehensive EHR and practice management solution specifically crafted for behavioral health practices, regardless of their size. Valant is designed to enable you to minimize the time spent on administrative duties, allowing for more focus on providing high-quality care to both individuals and groups. Streamline your workflow by: - Alleviating documentation burdens with a system that automatically creates clinical narratives, nearly finishing your notes for you. - Scheduling over 80 integrated, reportable outcome measures to be sent to patients automatically via the MYIO Patient Portal prior to their appointments. - Allowing the system to generate a coded charge when you document appointments. - Automating the patient onboarding experience so intake packets are readily available for patients to sign within their portal. - Receiving service requests directly through your EHR, effectively managing new patient inquiries, and obtaining a data-driven match score for prospective patients, thereby enhancing your practice's efficiency and patient satisfaction.

Altis Labs has introduced Nota, a groundbreaking platform aimed at improving the efficiency of therapeutic research and development in the clinical field. By leveraging artificial intelligence, Nota assesses imaging data to forecast patient outcomes, enabling sponsors to better concentrate on their most viable therapies. This cutting-edge tool equips researchers with the ability to utilize imaging data from clinical trials, access predictive biomarkers, and accelerate research initiatives on a broader scale. With Altis' cloud-based software that employs deep learning techniques, biopharma companies can achieve comprehensive outcome predictions at the levels of individual images, patients, and entire cohorts, thereby enhancing the design of clinical trials and boosting confidence in predicting clinical endpoints. The insights provided by Nota hold the potential to significantly shorten development timelines, reduce drug development costs, and increase the likelihood of success in clinical trials across diverse therapeutic areas. Furthermore, Nota signifies a major leap forward in the fusion of technology with clinical research, ultimately paving the way for more streamlined and effective drug development methodologies. This innovation not only promises to transform the landscape of clinical trials but also aims to improve patient outcomes in the long run.